Results 91 to 100 of about 5,456,142 (288)

High‐Throughput Quantitative Chemical Shift‐Encoded MRI of the Liver

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Access to MRI is limited by lengthy exam times and inefficient utilization. Focused protocols can reduce exam times, but workflow variability and inefficient room turnaround contribute to conservative scheduling with long exam slots.
Garrett C. Fullerton, Jiayi Tang, Jitka Starekova, Julius F. Heidenreich, Ali Pirasteh, David T. Harris, Daiki Tamada, Collin J. Buelo, Dan W. Rettmann, Diego Hernando, Scott B. Reeder   +10 more
wiley   +1 more source

Global Co‐Occurrence Patterns of Ischemic Heart Disease and Metabolic Dysfunction–Associated Steatotic Liver Disease: Spatial Clusters, Risk Factors, and Quality‐of‐Care Index

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Ischemic heart disease and metabolic dysfunction–associated steatotic liver disease represent significant global health challenges, characterized by overlapping pathophysiological mechanisms.
Wei Wang, Wei‐dong Jiang, Lin Wang, Jin‐hui Sun, Zi‐jia Li, Ze‐zhong Wu, Ai‐qiong Qin, Shi Qiu, Wen Liu   +8 more
doaj   +1 more source

Spatial genomics: mapping human steatotic liver disease [PDF]

Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease) is a leading cause of chronic liver disease worldwide.
Paris, Jasmin, Matchett, Kylie P, Teichmann, Sarah A, Henderson, Neil C   +3 more
core   +1 more source

Drug-related problems and dosage adjustment in patients with liver disease [PDF]

, 2012
The liver is essential for the metabolism of medicinal substances. Liver disease, especially liver cirrhosis, may lead to various pharmacokinetic and pharmacodynamic changes, predisposing patients with liver cirrhosis to adverse drug events (ADEs).
Franz, Carmen Carina
core   +1 more source

Probiotics and intestinal permeability in adults with metabolic dysfunction‐associated steatohepatitis: A secondary analysis of a randomized clinical trial

Journal of Parenteral and Enteral Nutrition, EarlyView.
Abstract Background Metabolic dysfunction‐associated steatohepatitis (MASH) is associated with altered intestinal permeability, allowing microbial products to translocate to the liver via the enterohepatic circulation and contributes to disease progression. The aim of our study was to evaluate the association between probiotic supplementation and serum
Bruna Concheski de Moura, Samanta Catherine Ferreira, Amanda Souza Silva‐Sperb, Helena Abadie Moraes, Larisse Longo, Carolina Uribe‐Cruz, Matheus Truccolo Michalczuk, Themis Reverbel da Silveira, Carlos Thadeu Schmidt Cerski, Mário Reis Álvares da Silva, Valesca Dall'Alba   +10 more
wiley   +1 more source

The impact of steatotic liver disease on coronary artery disease through changes in the plasma lipidome

Scientific Reports
Steatotic liver disease has been shown to associate with cardiovascular disease independently of other risk factors. Lipoproteins have been shown to mediate some of this relationship but there remains unexplained variance.
Elias Björnson, Dimitrios Samaras, Malin Levin, Fredrik Bäckhed, Göran Bergström, Anders Gummesson   +5 more
doaj   +1 more source

The Cardiohepatic Axis in Metabolic Disease

JACC: Basic to Translational Science
Summary: Heart and liver metabolic diseases often coexist because of local and systemic disorders that affect both organs via cardio-hepatic interactions.
Andrew Hakeem, MSc, Jop van Berlo, MD, PhD, Xavier S. Revelo, PhD   +2 more
doaj   +1 more source

Hypertransaminasemia in hospitalized children: Insights from a national multicenter study by the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Hypertransaminasemia is a frequent finding in hospitalized children with common pediatric illnesses, often considered a transitory phenomenon associated with systemic inflammation/injury. This study aims to assess the prevalence and causes of incidentally detected hypertransaminasemia in children admitted to general pediatric units ...
Angelo Di Giorgio, Giusy Ranucci, Pietro Aliberti, Carmela Pia Senatore, Camilla Calì, Angelo Mazza, Francesca Sbravati, Patrizia Alvisi, Maurizio Giuseppe Fuoti, Ilaria Rochira, Antonio Marseglia, Maria Rosa Pastore, Annalisa Madeo, Alessandro La Rosa, Federica Ferrari, Fortunata Sabrina Civitelli, Valentina Maffini, Icilio Dodi, Serena della Femina, Andrea Colangelo, Lorenzo D'Antiga, Claudia Mandato   +21 more
wiley   +1 more source

Mid‐upper arm circumference, steatosis indices, and elastography for screening liver steatosis in children with overweight/obesity: A prospective cross‐sectional study

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Metabolic dysfunction–associated steatotic liver disease (MASLD) is common in children, and practical screening approaches are needed in populations with overweight/obesity. We aimed to evaluate mid‐upper arm circumference (MUAC) as a simple marker for ultrasonography (US)‐detected liver steatosis (LS) in children with overweight ...
Selcuk Teke, Tugba Cavis, Yasin Maruf Ergen, Birce Izgi Akcay, Edibe Gozde Basaran, Necati Balamtekin   +5 more
wiley   +1 more source

Children's and caregivers' experiences, information needs, and willingness to change lifestyle in metabolic dysfunction‐associated steatotic liver disease care: A multicenter study across Europe

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective Little is known about children's and caregivers' experiences, information needs, and willingness to change lifestyle following evaluation for metabolic dysfunction‐associated steatotic liver disease (MASLD). This study assessed these aspects across European hepatology clinics.
Anne‐Sophie R. Stroes, Natalia Zavhorodnia, Claudia Mandato, Antonella Mosca, Maria Mercadal‐Hally, Jernej Brecelj, Corina Pienar, Wojciech Jańczyk, Christian A. Hudert, Eberhard Lurz, Cigdem Arikan, Anastasia Konidari, Maarten Buytaert, Sander Lefere, Ruth De Bruyne, Hadar Moran‐lev, Guusje H. J. van Giesen, Anita C. E. Vreugdenhil, Marc A. Benninga, Bart G. P. Koot, Steatotic Liver Disease Special Interest Group of ESPGHAN   +20 more
wiley   +1 more source